Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Validation of Homogenization – V 2.0

Posted on By

SOP for Validation of Homogenization – V 2.0

Procedure for Validation of Homogenization

Department Quality Assurance (QA)/Production/Research & Development (R&D)
SOP No. SOP/Ointment/112
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define the process for validating homogenization in ointment manufacturing. The homogenization process ensures uniform particle size distribution, consistency, and stability of the final product.

2. Scope

This SOP applies to all personnel in the Quality Assurance (QA), Production, and Research & Development (R&D) departments responsible for validating the homogenization process in ointment manufacturing.

3. Responsibilities

  • Production Supervisor: Oversees the homogenization process and ensures adherence to validation protocols.
  • QA Officer: Verifies that the homogenization process meets regulatory and GMP requirements.
  • R&D Scientist: Determines critical homogenization parameters for product consistency.
  • Validation Team: Conducts validation trials and compiles data.
  • QA Manager: Approves the homogenization validation protocol and final validation report.
See also  Ointments: SOP for Ensuring Calibration of Critical Instruments - V 2.0

4. Accountability

The QA and Production Managers are accountable for ensuring that the homogenization validation process complies with regulatory guidelines and Good Manufacturing Practices (GMP).

5. Procedure

5.1 Validation Planning

  • Prepare a Homogenization Validation Protocol detailing:
    • Objective and scope of validation
    • Batch size and equipment used
    • Homogenization pressure, time, and speed
    • Acceptance criteria for uniformity, viscosity, and particle size
  • Identify sampling points for evaluation of process parameters.
  • Ensure homogenization equipment
is calibrated and in optimal condition before validation.

5.2 Execution of Validation Batches

  • Conduct a minimum of three consecutive validation batches to confirm process consistency.
  • Ensure that each batch follows the same homogenization procedure, including:
    • Pre-homogenization mixing conditions
    • Homogenization pressure and speed settings
    • Duration of homogenization
    • Cooling conditions post-homogenization
  • Collect in-process samples at predefined intervals.

5.3 Testing and Evaluation of Validation Data

  • Test each sample for critical quality attributes, including:
    • Particle size distribution
    • Viscosity
    • Homogeneity of active ingredients
    • pH stability
    • Phase separation
  • Compile all data and compare results with predefined acceptance criteria.

5.4 Process Optimization

  • If deviations occur, adjust homogenization parameters accordingly.
  • Conduct additional validation trials if necessary.
  • Document all process optimizations in the Validation Report.

5.5 Approval and Finalization

  • QA must review and approve the Homogenization Validation Report.
  • Final validated parameters must be incorporated into the Master Batch Record (MBR).
  • Maintain validation records for regulatory audits and inspections.

6. Abbreviations

  • GMP – Good Manufacturing Practices
  • QA – Quality Assurance
  • QC – Quality Control
  • R&D – Research & Development
  • MBR – Master Batch Record

7. Documents

  • Homogenization Validation Protocol (Annexure-1)
  • Homogenization Validation Report (Annexure-2)

8. References

  • ICH Q8 – Pharmaceutical Development
  • WHO GMP Guidelines for Process Validation
  • US FDA Process Validation Guidance

9. SOP Version

Version 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Homogenization Validation Protocol

Validation Parameter Specification Acceptance Criteria
Homogenization Pressure 100-300 bar ±10% Variation
Speed 2000-4000 rpm Within Set Limits
Homogenization Time 10-30 minutes No Phase Separation

Annexure-2: Homogenization Validation Report

Batch Number Pressure Speed Particle Size Viscosity Final Approval
OINT-1201 250 bar 3500 rpm Compliant Pass QA Manager
OINT-1202 275 bar 3000 rpm Compliant Pass QA Manager

12. Revision History:

Revision Date Revision No. Details of Revision Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP QA Head
01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
See also  Ointments: SOP for Evaluating Sensory Attributes of Ointments - V 2.0
Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

Post navigation

Previous Post: Capsule: SOP for Cleaning Dispensing Equipment – V 2.0
Next Post: Aerosol: SOP for Handling Deviations in Manufacturing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version